Trial intelligence / Profile preview

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

NCT00837707Phase 4Unknown

Start
Jun 2008
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aripiprazole in tardive dyskinesia (TD). Status: unknown.

02

Drugs

aripiprazole
03

Conditions

tardive dyskinesia (TD)

Beyond the preview

Go deeper on NCT00837707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00837707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call